These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11764861)

  • 1. Combination therapy for type 2 diabetes.
    Bell DS
    Am Fam Physician; 2001 Dec; 64(11):1812, 1814. PubMed ID: 11764861
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination sulfonylurea-insulin therapy in the treatment of noninsulin-dependent diabetes mellitus.
    Rosenblatt J
    Conn Med; 1991 Nov; 55(11):634-6. PubMed ID: 1790695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combination therapy insulin and sulfonylurea compounds. A critical analysis].
    Ratzmann KP; Berger M
    Z Arztl Fortbild (Jena); 1990; 84(21):1105-7. PubMed ID: 2281698
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination therapy with insulin and sulfonylurea].
    Bachmann W
    Dtsch Med Wochenschr; 1988 Apr; 113(16):652-4. PubMed ID: 3282863
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE; Hoehns JD
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of diabetes.
    Tripathy BB; Samal KC
    J Assoc Physicians India; 1983 Apr; 31(4):235-40. PubMed ID: 6358183
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination insulin and sulfonylurea compounds in the therapy of type II diabetes mellitus].
    Diem P
    Schweiz Med Wochenschr; 1990 Jul; 120(27-28):987-8. PubMed ID: 2197718
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Aug; 29(8):1990-1. PubMed ID: 16873829
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
    Farooki A; Schneider SH
    Diabetes Care; 2006 Aug; 29(8):1989-90. PubMed ID: 16873827
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case from practice (158). Type I diabetes in remission. Type II diabetes].
    Skoda C; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Jan; 79(1-2):25-6. PubMed ID: 2404332
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversation with ... Ralph DeFronzo, MD: dealing with the older diabetic. Interview by Richard L. Peck.
    DeFronzo R
    Geriatrics; 1986 Dec; 41(12):89-92. PubMed ID: 3536668
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 18. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 20. Follow-up of intensive glucose control in type 2 diabetes.
    Petrie JR
    N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.